Finance

Lists
002589:SHE
Realcan Pharmaceutical Group Co Ltd
3,05 CNY
-0,97%
(-0,030) 1D
16 ოქტ, 14:13:09 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002589...
Open
3,13 CNY
High
3,23 CNY
Low
3,03 CNY
Mkt. cap
4,91 მლრდ.
Avg. vol.
106,49 მლნ.
Volume
82,51 მლნ.
Dividend
0,07%
Quarterly dividend
0,00 CNY
Ex-dividend date
30 ივნ. 2026
P/E ratio
505,80
52-wk high
4,69 CNY
52-wk low
2,38 CNY
EPS
0,01 CNY
Shares outstanding
1,50 მლრდ.
No. of employees
2 ათ.
Open
3,13 CNY
High
3,23 CNY
Low
3,03 CNY
Mkt. cap
4,91 მლრდ.
Avg. vol.
106,49 მლნ.
Volume
82,51 მლნ.
Dividend
0,07%
Quarterly dividend
0,00 CNY
Ex-dividend date
30 ივნ. 2026
P/E ratio
505,80
52-wk high
4,69 CNY
52-wk low
2,38 CNY
EPS
0,01 CNY
Shares outstanding
1,50 მლრდ.
No. of employees
2 ათ.
News stories
From web sources and news partners
About Realcan Pharmaceutical Group Co Ltd
CEO-
Employees2,41 ათ.
Founded21 სექ. 2004
Headquarters-
SectorHealth care provider
Websiterealcan.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,86 მლრდ.
1,89 მლრდ.
1,71 მლრდ.
1,71 მლრდ.
Cost of goods sold
1,61 მლრდ.
1,74 მლრდ.
1,49 მლრდ.
1,54 მლრდ.
Cost of revenue
1,61 მლრდ.
1,74 მლრდ.
1,49 მლრდ.
1,54 მლრდ.
Research and development expenses
5,31 მლნ.
4,40 მლნ.
2,71 მლნ.
3,48 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
175,68 მლნ.
128,25 მლნ.
144,14 მლნ.
143,12 მლნ.
Operating expense
170,72 მლნ.
175,33 მლნ.
155,66 მლნ.
141,50 მლნ.
Total operating expenses
1,78 მლრდ.
1,92 მლრდ.
1,64 მლრდ.
1,68 მლრდ.
Operating income
79,41 მლნ.
-29,77 მლნ.
62,58 მლნ.
25,97 მლნ.
Other non operating income
-43,53 მლნ.
-34,43 მლნ.
-2,05 მლნ.
22,05 მლნ.
EBT including unusual items
19,93 მლნ.
-1,86 მლნ.
16,32 მლნ.
21,74 მლნ.
EBT excluding unusual items
22,05 მლნ.
-2,72 მლნ.
16,16 მლნ.
21,73 მლნ.
Income tax expense
23,53 მლნ.
-18,76 მლნ.
697,10 ათ.
7,03 მლნ.
Effective tax rate
118,07%
1 009,59%
4,27%
32,32%
Other operating expenses
12,43 მლნ.
8,46 მლნ.
8,65 მლნ.
8,20 მლნ.
Net income
-6,03 მლნ.
3,93 მლნ.
10,37 მლნ.
763,09 ათ.
Net profit margin
-0,32%
0,21%
0,61%
0,04%
Earnings per share
-
-
-
-
Interest and investment income
25,13 მლნ.
83,49 მლნ.
10,96 მლნ.
14,56 მლნ.
Interest expense
-38,96 მლნ.
-22,01 მლნ.
-55,32 მლნ.
-40,85 მლნ.
Net interest expenses
-13,83 მლნ.
61,48 მლნ.
-44,36 მლნ.
-26,29 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
119,81 მლნ.
7,54 მლნ.
99,89 მლნ.
56,35 მლნ.
Gain or loss from assets sale
173,18 ათ.
-1,82 მლნ.
-
-188,56 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები